AI assistant
Elos Medtech — M&A Activity 2021
Jun 1, 2021
3039_iss_2021-06-01_1d9510f0-1fc7-49dc-905a-2920a05ea0e7.pdf
M&A Activity
Open in viewerOpens in your device viewer
Elos Medtech statement regarding recent share price development: talks regarding a possible takeover bid are ongoing
Elos Medtech AB (publ) has noted the recent share price development. The Board of Directors announces that, commencing a little more than two weeks ago, it is in discussions with a party concerning a possible takeover bid for Elos Medtech. The party has indicated an offer price of SEK 215 per share in cash on a non-binding basis.
There can be no certainty that a takeover bid will be made, nor as to the terms of any such offer. Elos Medtech will make further announcements as and when appropriate.
Gothenburg, June 1, 2021
The Board of Directors at Elos Medtech AB (publ)
For further information, please contact:
Yvonne Mårtensson, Chairman of the Board, +4670 833 77 82, email: [email protected]
For additional information about the Elos Medtech Group, visit www.elosmedtech.com
This information is information that Elos Medtech AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above on June 1, 2021, at 23:20 (CET).